First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.
about
Systematic coarse-grained modeling of complexation between small interfering RNA and polycationsTargeted polymeric nanoparticles for cancer gene therapy.Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy.Twist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis.Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.Application of bee venom and its main constituent melittin for cancer treatment.Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes.In vitro effects of Staphylococcus aureus enterotoxin C3 on T cell activation, proliferation and cytokine production.Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery diseaseContinuous Production of Discrete Plasmid DNA-Polycation Nanoparticles Using Flash Nanocomplexation.Structural Comparisons of PEI/DNA and PEI/siRNA Complexes Revealed with Molecular Dynamics Simulations.Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies.Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.Role of Gene Therapy in Pancreatic Cancer-A Review.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclaturePerformance of Pyridylthiourea-Polyethylenimine Polyplex for siRNA-Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models
P2860
Q36385485-9B8400EB-B0A9-4AF6-8255-656314E6A7ADQ36416427-006A253C-7922-47E7-A55E-ADCC6D943458Q36654542-4A190E6D-14BC-47EB-8C53-B7AB6457ED65Q37295501-6E86FB99-FC7D-4F2B-BA63-8758FAE38C51Q37691056-62BA39DA-B2CA-4D01-ACEC-796DB23CDC83Q38966140-28A31310-5B2D-4711-927D-3B823F925D3CQ39359422-67C705C9-43D0-4645-A2ED-EA892A0F5973Q40076515-0C085105-1177-4CA7-ABB4-C229F484E61AQ42321217-C3D78EE6-2895-4882-A693-E4C01B20D512Q45346878-F5949824-ACE0-411E-A185-F974587192B4Q45864137-085ECDB0-6C77-45CB-B243-1B730844FF4CQ48282746-0CF5D102-59D2-476F-92E2-4FA0013DDCCAQ52568331-E7A66139-624A-48FF-9D33-34A75A61C235Q52579251-1ECE5416-6ECF-4A4E-82EF-97D912671F73Q52610258-C97C860B-5EC9-4BD8-BEAE-967254702085Q57144951-66655875-B23B-4785-A20A-A343F395C913Q58002758-1F381013-33B8-43B5-B6E1-754AB42297D0
P2860
First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
First-in-man phase 1 clinical ...... preliminary clinical findings.
@ast
First-in-man phase 1 clinical ...... preliminary clinical findings.
@en
type
label
First-in-man phase 1 clinical ...... preliminary clinical findings.
@ast
First-in-man phase 1 clinical ...... preliminary clinical findings.
@en
prefLabel
First-in-man phase 1 clinical ...... preliminary clinical findings.
@ast
First-in-man phase 1 clinical ...... preliminary clinical findings.
@en
P2093
P2860
P50
P356
P1433
P1476
First-in-man phase 1 clinical ...... preliminary clinical findings.
@en
P2093
Aline Meulle
Alix Vignolle-Vidoni
Barbara Bournet
Fabian Gross
Fabienne Vernejoul
Frédéric Lopez
Gilles Cambois
Gérard Tiraby
Hubert Lulka
Jérôme Torrisani
P2860
P304
P356
10.1038/MT.2015.1
P577
2015-01-14T00:00:00Z